MENLO PARK, Calif., Jan. 4, 2018 /PRNewswire/ — Forty Seven Inc., a clinical-stage company focused on developing the next generation of transformational immuno-oncology treatments to enable patients’ immune systems to defeat their cancer, today announced that Forty Seven’s President and…
